Skip to main content
All lobbying filings

Chartwell Strategy Group LLC

Chartwell Strategy Group LLC filed a Q3 report for Amazon.com (FRA Pillpack AN Amazon Company) on October 15, 2026, reporting $40,000 in lobbying income.

Lobbying for Amazon.com (FRA Pillpack AN Amazon Company) · Pharmacy

As filed: CHARTWELL STRATEGY GROUP LLC for AMAZON.COM (FRA PILLPACK AN AMAZON COMPANY).

All filings by Chartwell Strategy Group LLC · Everything Amazon.com (FRA Pillpack AN Amazon Company) has reported

 Filing · LD-2 quarterly report Q3 report
Reporting period
3rd Quarter 2026
July 1 - Sep 30 · Posted Oct 15, 2026
Income
$40,000
What the client paid this registrant for the period.
Client based in
New Hampshire

Official filing document

 Lobbyists on this filing 2
  • ADAM BORDES
    Previously held: Committee on Oversight and Government Reform; Office of Congressman Louis Stokes; Office of Congressman William L. Clay, Sr.
  • OSWALDO J PALOMO
    Previously held: L.A., Rep. Walsh; Staff Assistant, Rep. Walsh

A "covered position" is a government job the lobbyist held in the 20 years before registering, which the law requires them to name. See the revolving door for former members of Congress across all filings.

 Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

 Lobbying activity 3
Pharmacy

Monitor legislation on drug pricing/transparency, market access, and industry competition issues (including draft transparency legislation concerning health-related ownership information) Monitor FY 2027 Appropriations for HHS Monitor FY 2027 NDAA for TRICARE Pharmacy related provisions Monitor international trade issues. Monitor permitting reform legislation Monitor labor issues Monitor and engage on H.R. 9340, the Ratepayer Protection Act

Transportation

Monitor legislation on drug pricing/transparency, market access, and industry competition issues (including draft transparency legislation concerning health-related ownership information) Monitor FY 2027 Appropriations for HHS Monitor FY 2027 NDAA for TRICARE Pharmacy related provisions Monitor international trade issues. Monitor permitting reform legislation Monitor labor issues Monitor and engage on H.R. 9340, the Ratepayer Protection Act

Energy/Nuclear

Monitor legislation on drug pricing/transparency, market access, and industry competition issues (including draft transparency legislation concerning health-related ownership information) Monitor FY 2027 Appropriations for HHS Monitor FY 2027 NDAA for TRICARE Pharmacy related provisions Monitor international trade issues. Monitor permitting reform legislation Monitor labor issues Monitor and engage on H.R. 9340, the Ratepayer Protection Act

 Bills named in this filing 1

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem